Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada.
McGill Center for Bioinformatics, McGill University, Montreal, Canada.
Mol Oncol. 2018 Jun;12(6):775-787. doi: 10.1002/1878-0261.12168. Epub 2018 Apr 27.
Glioblastoma (GBM) is the most common and deadly malignant brain cancer of glial cell origin, with a median patient survival of less than 20 months. Transcription factors FOXG1 and TLE1 promote GBM propagation by supporting maintenance of brain tumour-initiating cells (BTICs) with stem-like properties. Here, we characterize FOXG1 and TLE1 target genes in GBM patient-derived BTICs using ChIP-Seq and RNA-Seq approaches. These studies identify 150 direct FOXG1 targets, several of which are also TLE1 targets, involved in cell proliferation, differentiation, survival, chemotaxis and angiogenesis. Negative regulators of NOTCH signalling, including CHAC1, are among the transcriptional repression targets of FOXG1:TLE1 complexes, suggesting a crosstalk between FOXG1:TLE1 and NOTCH-mediated pathways in GBM. These results provide previously unavailable insight into the transcriptional programs underlying the tumour-promoting functions of FOXG1:TLE1 in GBM.
胶质母细胞瘤(GBM)是最常见和最致命的神经胶质细胞来源的恶性脑肿瘤,中位患者生存时间不到 20 个月。转录因子 FOXG1 和 TLE1 通过支持具有干细胞样特性的脑肿瘤起始细胞(BTICs)的维持来促进 GBM 的增殖。在这里,我们使用 ChIP-Seq 和 RNA-Seq 方法在 GBM 患者来源的 BTIC 中对 FOXG1 和 TLE1 的靶基因进行了表征。这些研究确定了 150 个直接的 FOXG1 靶标,其中一些也是 TLE1 的靶标,涉及细胞增殖、分化、存活、趋化性和血管生成。NOTCH 信号通路的负调节剂,包括 CHAC1,是 FOXG1:TLE1 复合物转录抑制靶标的一部分,表明在 GBM 中,FOXG1:TLE1 和 NOTCH 介导的途径之间存在串扰。这些结果为 FOXG1:TLE1 在 GBM 中的肿瘤促进功能的转录程序提供了以前无法获得的见解。